Latest news
Is GRAIL (GRAL) Fairly Valued Following Galleri Adoption Growth And The FDA Panel Date? - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 05:12:00 GMTFDA panel to review Grail's blood-based cancer test - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 21:32:11 GMTLuxe Aquariums & Grail Fish with Fluid Dynamics International - Dan’s PapersDan’s Papers · Fri, 07 Aug 2026 21:15:05 GMTUS FDA to hold advisory meeting to review Grail's multi-cancer test - ReutersReuters · Fri, 07 Aug 2026 18:51:34 GMTFDA sets advisory panel for Galleri multicancer screening test - MedTech DiveMedTech Dive · Fri, 07 Aug 2026 17:39:34 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTGRAIL to face FDA AdCom for Galleri cancer test (GRAL:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 15:43:36 GMTFDA panel to review GRAIL’s cancer detection test on Sept. 23 - Investing.com CanadaInvesting.com Canada · Fri, 07 Aug 2026 15:13:16 GMT